Dental PlaqueNCT04006483
Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque
An observational study of Dental Plaque, run by Procter and Gamble at 1 site in United States.
Trial summary
The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Dental Plaque
- What is being tested?
- Stannous fluoride dentifrice
- How many people
- 2,359 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Jan 2018to 30 Nov 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: This meta-analysis includes healthy adult male and females.
Subjects were excluded from this study for the following reasons;
- pregnancy,
- rampant caries,
- severe periodontitis,
- at discretionary of the Principal Investigator.
Trial locations and contacts
1 site in 1 country.
United States1 site
Multiple P&G Investigation Clinical Sites
Cincinnati, Ohio, 45040
About this study
Official title: A Review of Meta-Analyses on Bioavailable Stannous Fluoride Dentifrices: Effects on Dental Plaque
The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.
- Conditions
- Dental Plaque
- Being tested
- Stannous fluoride dentifrice, Positive control dentifrice, Negative control dentifrice
- Medical subject headings
- Dental Plaque
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stannous fluoride dentifriceDrug
Stannous fluoride (0.454%) dentifrice
Positive control dentifriceDrug
Positive control dentifrice containing (0.3%) triclosan.
Negative control dentifriceDrug
Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)
| Study group | Role | What they receive |
|---|---|---|
| Stannous Fluoride Dentifrice | Twice daily brushing Receives: Drug: Stannous fluoride dentifrice | |
| Positive control dentifrice | Twice daily brushing Receives: Drug: Positive control dentifrice | |
| Negative control dentifrice | Twice daily brushing Receives: Drug: Negative control dentifrice |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dental Plaque Scores
Change from baseline as measured by mean plaque score reduction from baseline (via Quigley-Hein, Turesky Modification Index or Rustogi Modification of the Navy Plaque index).
Measured: Up to 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jul 2019
- Study start8 Jan 2018
- Primary completion30 Nov 2018
- Study completion30 Nov 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dental PlaqueStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 2,359 participants (actual)
Sponsor and investigators
- Lead sponsor
- Procter and Gamble
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04006483
- Sponsor's protocol ID
- 2019SnF2PlaqueAnalysis
- Status last verified
- Nov 2023
- First submitted
- 1 Jul 2019
- Last updated
- 18 Nov 2023
- Results posted
- No
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Review of Meta-Analyses on Bioavailable Stannous Fluoride Dentifrices: Effects on Dental Plaque
- ClinicalTrials.gov ID
- NCT04006483
- Acronym / sponsor ID
- 2019SnF2PlaqueAnalysis
- Conditions
- Dental Plaque
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,359 participants (actual)
- Lead sponsor
- Procter and GambleIndustry (pharma, biotech, devices)
- Study start
- 8 Jan 2018 (actual)
- Primary completion
- 30 Nov 2018 (actual)
- Study completion
- 30 Nov 2018 (actual)
- First posted
- 5 Jul 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Stannous Fluoride Dentifrice | – | Drug: Stannous fluoride dentifriceTwice daily brushing |
| Positive control dentifrice | – | Drug: Positive control dentifriceTwice daily brushing |
| Negative control dentifrice | – | Drug: Negative control dentifriceTwice daily brushing |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- This meta-analysis includes healthy adult male and females.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stannous fluoride dentifriceStannous fluoride (0.454%) dentifrice | Drug | Stannous Fluoride Dentifrice |
| Positive control dentifricePositive control dentifrice containing (0.3%) triclosan. | Drug | Positive control dentifrice |
| Negative control dentifriceNegative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%) | Drug | Negative control dentifrice |
Primary outcome
Dental Plaque Scores
Time frame: Up to 12 weeks
Change from baseline as measured by mean plaque score reduction from baseline (via Quigley-Hein, Turesky Modification Index or Rustogi Modification of the Navy Plaque index).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2023.
Related trials for Dental Plaque
Active, not recruitingPhase 3
A Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis
Plaque, Gingivitis
Not yet recruiting
Effectiveness of Personalized Digital Oral Health Intervention in Patients With Fixed Orthodontic Appliances.
Oral Hygiene in Patients With Fixed Orthodontic Appliances, Dental Plaque
Not yet recruiting
Effect of Xylitol- Versus Erythritol-Sweetened Mints on Plaque ATP-Bioluminescence Readings
Dental Caries, Dental Plaque
Not yet recruitingObservational study
Plaque and Bleeding on Probing Around Implants Supporting Fixed Full-Arch Dental Prostheses
Peri-Implant Health
Not yet recruiting
Effectiveness of Oil Pulling Using Oils in Comparison With Mouthwash for Gingivitis
Gingivitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dental Plaque, run by Procter and Gamble at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dental Plaque Scores (time frame: Up to 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.